Main content
Andrew Dillon, National Institute for Health and Clinical Excellence
Stephen Sackur talks to Andrew Dillon of the National Institute for Health and Clinical Excellence, whose agency is responsible for deciding whether new drugs and treatments should be funded by the NHS.
Last on
Wed 31 Oct 2007
03:30GMT
麻豆社 News UK